Embedded Files
Hyperosmolar hyperglycaemic state (HHS) is a severe, life-threatening hyperglycaemic emergency. Though less common than diabetic ketoacidosis (DKA), HHS presents a significantly higher mortality risk, with fatality rates estimated to be 5-10 times greater than those of DKA.
Despite its severity, data on HHS remains limited, particularly pertaining to its epidemiology, clinical presentation, and patient outcomes. Building on the success of the DEKODE model for DKA, a similar multicentre surveillance system was adapted for DEKODE-HHS. This initiative is dedicated to advancing our understanding of HHS by examining its epidemiology, clinical features, outcomes, and the consistency of management practices with national guidelines.
Objectives
To monitor real-time trends in HHS epidemiology, presentation and outcomes, enabling early detection of adverse trends in management.
To assess hospital-specific performance in adherence with Joint British Diabetes Society (JBDS) guidelines and identify opportunities to enhance management practices, improving patient outcomes.
Identify barriers and facilitators to implementing clinical guidelines, fostering more effective and consistent care delivery.
How you can participate in DEKODE-HHS:
Email us to register your interest.
Register the audit at your local hospital and obtain approval from clinical governance.
Collect data on HHS admissions using a secure google-form based application.
Benefits of participating in the DEKODE-HHS initiative:
Develop a better understanding of your local HHS patient demographic and its presentation.
Gain valuable insights into hospital-specific standards of care for HHS management, enabling the implementation of targeted interventions tailored to your local region.
Enhance the collective understanding of HHS, leading to improved management practices among healthcare staff.
Dr Punith Kempegowda
DEVI Coordinator
Dr Tania Kew
DEKODE HHS Coordinator
Page updated
Google Sites
Report abuse